share_log

Would Anshan Hifichem (SZSE:300758) Be Better Off With Less Debt?

Simply Wall St ·  Oct 30, 2023 19:41

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. We can see that Anshan Hifichem Co., Ltd. (SZSE:300758) does use debt in its business. But should shareholders be worried about its use of debt?

What Risk Does Debt Bring?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. When we think about a company's use of debt, we first look at cash and debt together.

See our latest analysis for Anshan Hifichem

How Much Debt Does Anshan Hifichem Carry?

The image below, which you can click on for greater detail, shows that at September 2023 Anshan Hifichem had debt of CN¥852.0m, up from CN¥758.6m in one year. However, it does have CN¥286.9m in cash offsetting this, leading to net debt of about CN¥565.0m.

debt-equity-history-analysis
SZSE:300758 Debt to Equity History October 30th 2023

How Healthy Is Anshan Hifichem's Balance Sheet?

The latest balance sheet data shows that Anshan Hifichem had liabilities of CN¥748.5m due within a year, and liabilities of CN¥688.8m falling due after that. Offsetting this, it had CN¥286.9m in cash and CN¥399.8m in receivables that were due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by CN¥750.6m.

Given Anshan Hifichem has a market capitalization of CN¥4.11b, it's hard to believe these liabilities pose much threat. But there are sufficient liabilities that we would certainly recommend shareholders continue to monitor the balance sheet, going forward. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately the future profitability of the business will decide if Anshan Hifichem can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

In the last year Anshan Hifichem had a loss before interest and tax, and actually shrunk its revenue by 13%, to CN¥1.2b. We would much prefer see growth.

Caveat Emptor

Not only did Anshan Hifichem's revenue slip over the last twelve months, but it also produced negative earnings before interest and tax (EBIT). To be specific the EBIT loss came in at CN¥16m. Considering that alongside the liabilities mentioned above does not give us much confidence that company should be using so much debt. Quite frankly we think the balance sheet is far from match-fit, although it could be improved with time. However, it doesn't help that it burned through CN¥172m of cash over the last year. So suffice it to say we do consider the stock to be risky. The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately, every company can contain risks that exist outside of the balance sheet. To that end, you should be aware of the 1 warning sign we've spotted with Anshan Hifichem .

When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment